Nanobac, Eureka Genomics Ink Definitive Merger Deal
April 13, 2009
Nanobac, Eureka Genomics Ink Definitive Merger Deal
The merger will combine Eureka's bioinformatics capabilities with Nanobac's drug discovery program focused on inhibiting, destroying, or neutralizing calcifying nanoparticles.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Bioinformatics Briefs
February 20, 2009 / BioInform - Meetings and Deadlines
April 28, 2009 / Genome Technology - Bioinformatics Briefs
April 17, 2009 / BioInform - Bioinformatics Briefs
April 3, 2009 / BioInform - At AMIA Summit, Clinical and Translational Science Awardees Discuss Informatics Challenges
March 27, 2009 / BioInform